NASDAQ: ARTV
Artiva Biotherapeutics Inc Stock Ownership - Who owns Artiva Biotherapeutics?

Insider buying vs selling

Have Artiva Biotherapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
5am Partners VI LLC10% Owner2024-07-22833,333$12.00
$10.00MBuy
5am Partners VI LLC10% Owner2024-07-22348,721$10.20
$3.56MBuy
5am Partners VI LLC10% Owner2024-07-22112,966$10.20
$1.15MBuy
Gc Corp10% Owner2024-07-22416,666$12.00
$5.00MBuy
Gc Corp10% Owner2024-07-22256,316$10.20
$2.61MBuy
Gc Corp10% Owner2024-07-221,666,666$12.00
$20.00MBuy
Gc Corp10% Owner2024-07-22294,117$10.20
$3.00MBuy
Yongjun HuhDirector2024-07-22416,666$12.00
$5.00MBuy
Yongjun HuhDirector2024-07-22256,316$10.20
$2.61MBuy
Yongjun HuhDirector2024-07-221,666,666$12.00
$20.00MBuy

1 of 2

ARTV insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ARTV insiders and whales buy or sell their stock.

ARTV Shareholders

What type of owners hold Artiva Biotherapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Ra Capital Management LP40.44%9,853,302$22.07MInstitution
Yongjun Huh20.18%4,916,249$11.01MInsider
Gc Corp18.75%4,567,412$10.23MInsider
5am Partners VI LLC9.66%2,353,304$5.27MInsider
5am Venture Management LLC9.66%2,353,304$5.27MInstitution
Venbio Global Strategic Fund III LP7.95%1,936,637$4.34MInsider
Vr Adviser LLC6.61%1,609,569$3.61MInstitution
Venbio Partners LLC6.24%1,519,971$3.40MInstitution
Blackrock Inc4.29%1,046,353$2.34MInstitution
Capital World Investors3.76%915,386$2.05MInstitution

1 of 3

ARTV vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ARTV57.43%42.57%Net Buying
AGEN5.93%94.07%Net BuyingNet Buying
IOBT28.17%71.83%Net Selling
CABA75.81%8.32%
PMVP58.46%41.54%Net Buying

Artiva Biotherapeutics Stock Ownership FAQ

Who owns Artiva Biotherapeutics?

Artiva Biotherapeutics (NASDAQ: ARTV) is owned by 86.86% institutional shareholders, 64.40% Artiva Biotherapeutics insiders, and 0.00% retail investors. Yongjun Huh is the largest individual Artiva Biotherapeutics shareholder, owning 4.92M shares representing 20.18% of the company. Yongjun Huh's Artiva Biotherapeutics shares are currently valued at $11.80M.

If you're new to stock investing, here's how to buy Artiva Biotherapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.